Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Intra-Cellular Therapies Stock Soared 253% in December

TheMotleyFool

0 0

Why Intra-Cellular Therapies Stock Soared 253% in December

Intra-Cellular Therapies (NASDAQ: ITCI) stock outperformed a booming market last month by jumping 253% compared to a 3% spike in the S&P 500, according to data provided by S&P Global Market Intelligence.

The rally closed an impressive year for shareholders in the biotech stock, which rose 200% for the year to far outpace the market's 29% gain.

Image source: Getty Images.

Source Fool.com

Like: 0

ITCI

Share